Experts: Trump’s latest drug
pricing executive order faces uphill battle |
|||
Healio |
|||
President Donald J. Trump’s executive order that allows HHS to
cap certain prescription drug prices for Medicare to what he called the
“most-favored-nation price” will be difficult to implement, experts said. The
executive order, signed Sept. 13, states that Medicare Part B and Part D drug
prices will align with the lowest cost of a drug that is sold to any country
in the Organization for Economic Co-operation and Development that has a
“comparable per-capita gross domestic product.” |
|||
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Wednesday, September 23, 2020
Experts: Trump’s latest drug pricing executive order faces uphill battle
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment